Alport Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

• In 2022, diagnosed prevalence of Alport syndrome will reach to 359,000 cases across the 16 countries covered in the publisher's epidemiology forecast.
• There are no approved marketed products for the treatment of Alport syndrome.
• R&D activity in Alport syndrome is limited, with only one product in late-stage development.
• Reata pharmaceuticals dominate clinical trial development in Alport syndrome, with the US emerging as the key countries for conducting trials in Alport syndrome.
• No deal activity observed within the Alport syndrome space during the past 24 months.
• Therapeutic options for Alport syndrome patients continue to be limited, with only one therapy reaching the market during next 18 months.

Scope

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Alport Syndrome market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Alport Syndrome market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.